SecSonar.com

Cencora, Inc. (COR)

Cencora, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Cencora, Inc. (COR) is a Medical - Distribution company based in US with a market capitalization of $52B. Revenue grew 9.3% year-over-year and the company generated $3.2B in free cash flow. This page tracks COR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 47K employees · IPO Apr 4, 1995

Valuation

Valuation & price

$257.71 · as of May 17, 2026 · -31.2% vs 52w high

32.4

P/E ratio

Latest-FY diluted EPS

34.48

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$375$314$253Jul 25Dec 25Jul 26Jul 7, 25$302.50Jul 9, 25$300.16Jul 11, 25$295.21Jul 15, 25$294.65Jul 17, 25$294.38Jul 21, 25$292.67Jul 23, 25$293.44Jul 25, 25$290.36Jul 29, 25$289.77Jul 31, 25$286.08Aug 4, 25$293.64Aug 6, 25$283.78Aug 11, 25$290.70Aug 13, 25$291.04Aug 15, 25$292.82Aug 19, 25$294.71Aug 21, 25$303.23Aug 25, 25$288.30Aug 27, 25$290.56Aug 29, 25$291.61Sep 3, 25$295.14Sep 5, 25$292.50Sep 9, 25$298.67Sep 11, 25$302.80Sep 16, 25$290.00Sep 18, 25$290.84Sep 22, 25$288.79Sep 24, 25$308.36Sep 26, 25$307.00Sep 30, 25$312.53Oct 2, 25$308.57Oct 6, 25$305.30Oct 8, 25$310.61Oct 10, 25$318.00Oct 14, 25$317.93Oct 16, 25$319.40Oct 21, 25$328.82Oct 23, 25$328.56Oct 27, 25$336.05Oct 29, 25$333.17Oct 31, 25$337.81Nov 4, 25$344.53Nov 6, 25$360.24Nov 10, 25$364.65Nov 12, 25$363.42Nov 14, 25$361.94Nov 18, 25$361.64Nov 20, 25$362.07Nov 25, 25$374.75Nov 28, 25$368.93Dec 2, 25$350.67Dec 4, 25$337.63Dec 8, 25$337.82Dec 10, 25$340.79Dec 12, 25$346.00Dec 16, 25$341.72Dec 18, 25$340.58Dec 22, 25$340.03Dec 24, 25$339.98Dec 29, 25$340.21Jan 2, 26$338.87Jan 6, 26$346.17Jan 8, 26$335.74Jan 12, 26$342.16Jan 14, 26$349.93Jan 16, 26$354.85Jan 21, 26$351.75Jan 23, 26$353.48Jan 27, 26$356.14Jan 29, 26$352.10Feb 2, 26$363.56Feb 4, 26$329.97Feb 9, 26$363.27Feb 11, 26$365.70Feb 13, 26$360.83Feb 18, 26$360.23Feb 20, 26$361.08Feb 24, 26$364.38Feb 26, 26$366.65Mar 2, 26$372.65Mar 4, 26$368.19Mar 6, 26$358.46Mar 10, 26$352.19Mar 12, 26$352.65Mar 17, 26$334.71Mar 19, 26$331.74Mar 23, 26$320.61Mar 25, 26$325.08Mar 27, 26$312.45Mar 31, 26$314.14Apr 2, 26$324.80Apr 7, 26$320.89Apr 9, 26$322.46Apr 13, 26$319.12Apr 15, 26$317.58Apr 17, 26$327.56Apr 22, 26$308.30Apr 24, 26$308.19Apr 28, 26$311.99Apr 30, 26$308.01May 4, 26$303.66May 6, 26$252.74May 8, 26$261.08May 12, 26$260.93May 14, 26$261.11May 18, 26$261.87May 20, 26$264.75May 22, 26$274.91May 28, 26$267.71Jun 1, 26$264.69Jun 3, 26$263.64Jun 5, 26$275.04Jun 9, 26$279.57Jun 11, 26$281.48Jun 15, 26$281.43Jun 17, 26$277.09Jun 22, 26$271.28Jun 24, 26$284.47Jun 26, 26$286.13Jul 2, 26$296.51
$252.7452-week range$374.75
Loading valuation history…

Fundamentals

Key fundamentals

$52B

Market cap

9.3%

Revenue growth (YoY)

3.2%

Gross margin

$3.2B

Free cash flow (USD)

$6.4B

Net debt

-2.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$146.8BFY 2017$153.1BFY 2018$167.9BFY 2019$179.6BFY 2020$189.9BFY 2021$214.0BFY 2022$238.6BFY 2023$262.2BFY 2024$294.0BFY 2025$321.3B
$146.8B$321.3B

Free cash flow by year

2016 → 2025

FY 2016$2.7BFY 2017$1.0BFY 2018$1.1BFY 2019$2.0BFY 2020$1.8BFY 2021$2.2BFY 2022$2.2BFY 2023$3.5BFY 2024$3.0BFY 2025$3.2B
$2.7B$3.2B

Gross margin by year

2021 → 2025

FY 20212.9%FY 20223.2%FY 20233.0%FY 20243.0%FY 20253.2%
2.9%3.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $149KTyler Lauren M · Director · $148.6KJun 24, 2026Filing
  • Insider buyInsider Buy $1.1MDURCAN DERMOT MARK · Director · $1.1MJun 22, 2026Filing
  • 8-K eventExecutive Leadership ChangeJun 15, 2026Filing
  • 8-K eventCFO AppointmentMay 29, 2026Filing
  • Insider buyInsider Buy $1.1MDURCAN DERMOT MARK · Director · $1.1MMay 28, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is Cencora, Inc.'s market cap?

Cencora, Inc. (COR) has a market capitalization of $52B.

What is COR's P/E ratio?

COR trades at a price-to-earnings ratio of 32.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is COR's price-to-book (P/B) ratio?

COR trades at 34.48 times book value per share.

Are insiders buying COR stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at Cencora, Inc. in the last 90 days.

Same arena

Related companies in Medical - Distribution

CAH

Cardinal Health, Inc.

$46.2B

MCK

McKesson Corporation

$89.3B

HSIC

Henry Schein, Inc.

$8.8B

GRDN

Guardian Pharmacy Services, Inc.

$2.4B

PBH

Prestige Consumer Healthcare Inc.

$2.3B

ACH

Accendra Health, Inc.

$219.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.